Maastricht University Medical Center
Maastricht, Netherlands
NCT Number: NCT03077529
The population is aging worldwide, concomitant frailty is increased in older age groups. Frailty has a strong impact on outcomes of multi-morbidity and daily living, thereby negatively influencing quality of life and health care costs. Prevention or delay of onset of frailty associated with aging is needed. Dietary intake of galacto-oligosaccharides (GOS) may have beneficial effects on microbiota composition and health outcome parameters. As microbiota composition and function may be altered in elderly compared to younger adults, it will investigated whether the effects of GOS on selected parameters of microbiota and gut health differ between elderly versus younger adults. The primary objective of this study is to compare the effects of four weeks GOS supplementation on intestinal microbiota composition and activity in elderly versus younger adults. Further, this study has four secondary objectives. The study conforms to a randomized double-blind placebo-controlled cross-over design per age-group. Study populations are human volunteers (male and female), healthy young adults of 25-50 years and prefail older adults of 70-85 years old, BMI 20-30 kg/m2. One intervention period subjects will receive 7.2 grams of Vivinal® GOS Powder three times daily for four weeks. The other intervention period subjects will receive isocaloric placebo supplements (5.7 grams maltodextrin) three times daily for four weeks. At the start and end of each intervention period, several measurements will take place. There will be a washout period of four to five weeks between intervention periods. The main study parameter is the change in microbial composition and activity induced by GOS intervention, in younger adults and elderly.
Looking for future studies?
Notify Me25 year–85 year
All sexes
Interventional
Not applicable
Maastricht, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During this period subjects will receive 5.65 grams of Vivinal GOS supplements three times daily for four weeks
During this period subjects will receive 7.24 grams of maltodextrin supplements three times daily for four weeks
Time frame: Change from baseline to four weeks supplementation, of each intervention period
Microbiota composition and functional capacity as measured by HiSeq sequencing of fecal 16S rRNA genes.
Time frame: Change from baseline to four weeks supplementation, of each intervention period
Microbial activity as measured by metabolites, such as organic acids analysis in feces and plasma.
Maastricht University Medical Center
Other
Impact of Galacto-oligosaccharides on Microbial Fermentation Capacity and Markers of Frailty in Healthy Adults and Elderly
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07709065
Healthy Young Adults
Rzeszów, Poland
View Trial DetailsNCT07703930
Healthy Young Adults
Istanbul, Beylikduzu, Turkey (Türkiye)
View Trial DetailsNCT07702747
Healthy Young Adults
Montreal, Quebec, Canada
View Trial DetailsNCT07529678
Healthy Young Adults, Inactive People
Kubang Kerian, Kelantan, Malaysia
View Trial Details